Insider Deck research · News

JNJ stock news · Johnson & Johnson

Latest Johnson & Johnson (JNJ) stock news, headlines, and research context on Insider Deck. Market cap $621B.

News desk

Johnson & Johnson wire

Read the briefing on Insider Deck — headline, teaser, and desk context stay here. Publisher sites remain optional for the full longform.

6 on the wireUpdated within the hour

GuruFocus.com·Wed, Aug 5, 7:01 PM

Royalty Pharma PLC (RPRX) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance

Royalty Pharma PLC (RPRX) reports 14% total receipts growth and raises full-year 2026 guidance for the second consecutive quarter.

Insider Deck desk note

Last$257.59
Day+1.04%
SymbolJNJ

Cross-check the tape against filings and ownership — the headline is the spark; the desk is the research.

Frequently asked questions

What is the latest news on JNJ?

The JNJ news desk aggregates recent headlines with research context for Johnson & Johnson.

Where can I research JNJ on Insider Deck?

Johnson & Johnson (JNJ) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.